Cargando…
Meningiomas in patients with neurofibromatosis type 2 predominantly comprise ‘immunogenic subtype’ tumours characterised by macrophage infiltration
Although recent molecular analyses revealed that sporadic meningiomas have various genetic, epigenetic, and transcriptomic profiles, meningioma in patients with neurofibromatosis type 2 (NF2) have not been fully elucidated. This study investigated meningiomas' clinical, histological, and molecu...
Autores principales: | Teranishi, Yu, Miyawaki, Satoru, Nakatochi, Masahiro, Okano, Atsushi, Ohara, Kenta, Hongo, Hiroki, Ishigami, Daiichiro, Sakai, Yu, Shimada, Daisuke, Takayanagi, Shunsaku, Ikemura, Masako, Komura, Daisuke, Katoh, Hiroto, Mitsui, Jun, Morishita, Shinichi, Ushiku, Tetsuo, Ishikawa, Shumpei, Nakatomi, Hirofumi, Saito, Nobuhito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521403/ https://www.ncbi.nlm.nih.gov/pubmed/37752594 http://dx.doi.org/10.1186/s40478-023-01645-3 |
Ejemplares similares
-
Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index
por: Teranishi, Yu, et al.
Publicado: (2022) -
Brainstem intraparenchymal schwannoma with genetic analysis: a case report and literature review
por: Ishigami, Daiichiro, et al.
Publicado: (2021) -
Early prediction of functional prognosis in neurofibromatosis type 2 patients based on genotype–phenotype correlation with targeted deep sequencing
por: Teranishi, Yu, et al.
Publicado: (2022) -
NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas
por: Sakai, Yu, et al.
Publicado: (2022) -
Advances in Molecular Biological and Translational Studies in World Health Organization Grades 2 and 3 Meningiomas: A Literature Review
por: OKANO, Atsushi, et al.
Publicado: (2022)